GAD1 and depressive symptom measurement: We can conclude that the highest prevalence levels of GAD and depression correspond to those of the second wave of infections (57.3% and 54.19%, respectively) and that the lower levels were reported by the end of the third wave (43.21% and 43.65%, respectively).